News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,756 Results
Type
Article (85699)
Company Profile (703)
Press Release (747354)
Section
Business (232283)
Career Advice (4112)
Deals (39658)
Drug Delivery (122)
Drug Development (90704)
Employer Resources (194)
FDA (17985)
Job Trends (17277)
News (395643)
Policy (39627)
Tag
Academia (2974)
Alliances (56556)
Alzheimer's disease (1361)
Approvals (17912)
Artificial intelligence (171)
Bankruptcy (394)
Best Places to Work (12559)
Biotechnology (485)
Breast cancer (196)
Cancer (1452)
Cardiovascular disease (124)
Career advice (3517)
Cell therapy (317)
Clinical research (71988)
Collaboration (520)
Compensation (265)
COVID-19 (2811)
C-suite (119)
Data (1426)
Diabetes (180)
Diagnostics (6705)
Earnings (94796)
Employer resources (167)
Events (127317)
Executive appointments (411)
FDA (18682)
Funding (450)
Gene therapy (221)
GLP-1 (710)
Government (5049)
Healthcare (20731)
Infectious disease (2907)
Inflammatory bowel disease (126)
Interviews (808)
IPO (17636)
Job creations (5180)
Job search strategy (2856)
Layoffs (495)
Legal (10046)
Lung cancer (215)
Manufacturing (236)
Medical device (14439)
Medtech (14444)
Mergers & acquisitions (22151)
Metabolic disorders (513)
Neuroscience (1714)
NextGen Class of 2024 (7649)
Non-profit (5067)
Northern California (1732)
Obesity (292)
Opinion (249)
Patents (125)
People (64364)
Pharmaceutical (142)
Phase I (22187)
Phase II (31267)
Phase III (23560)
Pipeline (529)
Postmarket research (3548)
Preclinical (10010)
Radiopharmaceuticals (256)
Rare diseases (286)
Real estate (7373)
Regulatory (26101)
Research institute (2642)
Resumes & cover letters (649)
Southern California (1496)
Startups (4276)
United States (16213)
Vaccines (661)
Weight loss (229)
Date
Last 7 days (621)
Last 30 days (2448)
Last 365 days (37596)
2024 (37425)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1264)
Arizona (230)
Asia (49489)
Australia (8725)
California (4009)
Canada (1471)
China (319)
Colorado (183)
Connecticut (191)
Europe (113315)
Florida (546)
Georgia (145)
Illinois (453)
Indiana (239)
Maryland (682)
Massachusetts (3204)
Michigan (186)
Minnesota (313)
New Jersey (1157)
New York (1119)
North Carolina (880)
Northern California (1732)
Ohio (154)
Pennsylvania (951)
South America (1647)
Southern California (1496)
Texas (583)
Utah (115)
Washington State (433)
833,756 Results for "bio path holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024.
June 4, 2024
·
1 min read
Press Releases
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 24
December 13, 2024
·
1 min read
Business
Bio-Path Holdings Reports First Quarter 2024 Financial Results
Bio-Path Holdings, Inc. announced its financial results for the first quarter ended March 31, 2024 and provided an update on recent corporate developments.
May 15, 2024
·
7 min read
Drug Development
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
Bio-Path Holdings, Inc. announced an upcoming poster presentation at the 2024 European Hematology Association Congress, taking place June 13-16, 2024 in Madrid, Spain.
May 24, 2024
·
4 min read
Press Releases
Bio-Path Holdings Reports Third Quarter 2024 Financial Results
November 18, 2024
·
8 min read
Lone Star Bio
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
Bio-Path Holdings, Inc. announced an upcoming oral presentation at the American Society of Clinical Oncology Annual Meeting, taking place May 31 - June 4, 2024 in Chicago, IL.
May 23, 2024
·
4 min read
Lone Star Bio
Bio-Path Holdings Expands Global Patent Portfolio
Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, announced the receipt of newly issued patents in Mexico, Australia and Japan, and updated investors on the extent of its global intellectual property portfolio.
April 15, 2024
·
4 min read
Press Releases
Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients
December 12, 2024
·
9 min read
Press Releases
Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024
November 11, 2024
·
1 min read
Business
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
Bio-Path Holdings, Inc. announced that it will host a live conference call and audio webcast on Wednesday, May 15, 2024 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2024 and to provide a business overview.
May 8, 2024
·
1 min read
1 of 83,376
Next
